The global Trabecular Micro-Bypass Stent market is experiencing steady expansion as minimally invasive glaucoma surgery (MIGS) gains widespread clinical acceptance. Increasing prevalence of glaucoma, coupled with growing awareness of early intervention and pressure-lowering therapies, is significantly supporting market growth.